Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amdocs (DOX) Cash & Equivalents (2016 - 2025)

Amdocs (DOX) has disclosed Cash & Equivalents for 14 consecutive years, with $325.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Cash & Equivalents fell 6.09% to $325.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $325.0 million, a 6.09% decrease, with the full-year FY2025 number at $325.0 million, down 6.09% from a year prior.
  • Cash & Equivalents was $325.0 million for Q3 2025 at Amdocs, down from $346.1 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $709.1 million in Q3 2021 to a low of $325.0 million in Q3 2025.
  • A 5-year average of $494.7 million and a median of $520.1 million in 2023 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: crashed 33.46% in 2024, then fell 6.09% in 2025.
  • Amdocs' Cash & Equivalents stood at $709.1 million in 2021, then decreased by 19.14% to $573.4 million in 2022, then fell by 9.3% to $520.1 million in 2023, then plummeted by 33.46% to $346.1 million in 2024, then dropped by 6.09% to $325.0 million in 2025.
  • Per Business Quant, the three most recent readings for DOX's Cash & Equivalents are $325.0 million (Q3 2025), $346.1 million (Q3 2024), and $520.1 million (Q3 2023).